CONTACT INFORMATION http://www.loyola.org
Nina Clark
M.D.
  • Associate Professor
  • Medical Director, HIV Program
  • Medical Director, Infectious Disease/Transplant/Hematology-Oncology
  • Infectious Disease
Specialties
HIV, Infections in transplant recipients
Board Certifications
  • Infectious Disease - Subspecialty Cert: AM Board of Internal Medicine
Publications

Association of Genetic Variants With Rapid Fibrosis: Progression After Liver Transplantation for Hepatitis CLayden,J. E.; Tayo,B. O.; Cotler,S. J.; Clark,N. M.; Baraoidan,K.; Friedman,S. L.; Cooper,R. S.Transplantation 2014 ; ( ):

The risk of seizures among the carbapenems: a meta-analysisCannon,J. P.; Lee,T. A.; Clark,N. M.; Setlak,P.; Grim,S. A.The Journal of antimicrobial chemotherapy 2014 ;69(8):2043-2055

The use of fosfomycin to treat urinary tract infections in kidney transplant recipientsReid,G. E.; Grim,S. A.; Layden,J. E.; Akkina,S.; Tang,I.; Campara,M.; Clark,N. M.Transplantation 2013 ;96(3):e12-4

Evolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum beta-lactamases and carbapenemases)Lynch,J. P.,3rd; Clark,N. M.; Zhanel,G. G.Expert opinion on pharmacotherapy 2013 ;14(2):199-210

DNA viral infections complicating lung transplantationClark,N. M.; Lynch,J. P.,3rd; Sayah,D.; Belperio,J. A.; Fishbein,M. C.; Weigt,S. S.SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE 2013 ;34(3):380-404

Nocardia infections in solid organ transplantationClark,N. M.; Reid,G. E.; AST Infectious Diseases Community of PracticeAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2013 ;13 Suppl 4( ):83-92

Racial differences in fibrosis progression after HCV-related liver transplantationLayden,J. E.; Cotler,S.; Brown,K. A.; Lucey,M. R.; Te,H. S.; Eswaran,S.; Fimmel,C.; Layden,T. J.; Clark,N. M.Transplantation 2012 ;94(2):178-184

Impact of donor and recipient race on survival after hepatitis C-related liver transplantationLayden,J. E.; Cotler,S. J.; Grim,S. A.; Fischer,M. J.; Lucey,M. R.; Clark,N. M.Transplantation 2012 ;93(4):444-449

Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomesGrim,S. A.; Berger,K.; Teng,C.; Gupta,S.; Layden,J. E.; Janda,W. M.; Clark,N. M.The Journal of antimicrobial chemotherapy 2012 ;67(3):707-714

A multicenter study of histoplasmosis and blastomycosis after solid organ transplantationGrim,S. A.; Proia,L.; Miller,R.; Alhyraba,M.; Costas-Chavarri,A.; Oberholzer,J.; Clark,N. M.Transplant infectious disease : an official journal of the Transplantation Society 2012 ;14(1):17-23

Risk factors and outcomes associated with vancomycin-resistant Enterococcus infections with reduced susceptibilities to linezolidSantayana,E. M.; Grim,S. A.; Janda,W. M.; Layden,J. E.; Lee,T. A.; Clark,N. M.DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE 2012 ;74(1):39-42

Management of infectious complications in solid-organ transplant recipientsGrim,S. A.; Clark,N. M.Clinical Pharmacology & Therapeutics 2011 ;90(2):333-342

Gastrointestinal tuberculosis in renal transplant recipients: case report and review of the literatureJarrett,O.; Grim,S. A.; Benedetti,E.; Clark,N. M.Transplant Infectious Disease 2011 ;13(1):52-57

Development and implementation of a piperacillin-tazobactam extended infusion guidelineHeinrich,L. S.; Tokumaru,S.; Clark,N. M.; Garofalo,J.; Paek,J. L.; Grim,S. A.Journal of pharmacy practice 2011 ;24(6):571-576

Influenza: epidemiology, clinical features, therapy, and preventionClark,N. M.; Lynch,J. P.,3rdSeminars in Respiratory & Critical Care Medicine 2011 ;32(4):373-392

Levator defects affect perineal position independently of prolapse statusClark,N. A.; Brincat,C. A.; Yousuf,A. A.; Delancey,J. O.American Journal of Obstetrics and Gynecology 2010 ;203(6):595.e17-595.e22

CMV PCR as a diagnostic tool for CMV gastrointestinal disease after solid organ transplantationGrim,S. A.; Pereira,E.; Guzman,G.; Clark,N. M.Transplantation 2010 ;90(7):799-801

The impact of novel influenza A (H1N1) after hematopoietic SCTPatel,P.; Sweiss,K.; Shatavi,S.; Peace,D.; Clark,N.; Rondelli,D.Bone marrow transplantation 2010 ;45(12):1756-1757

Corynebacterium Striatum Septic Arthritis and Bacteremia: Case Report and ReviewBhayani,Nikhil; Simpkins,Heather; Janda,William M.; Berkes,Jamie; Clark,N. M.Infectious Diseases in Clinical Practice 2009 ;17(3):187

Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcomeSingh,N.; Aguado,J. M.; Bonatti,H.; Forrest,G.; Gupta,K. L.; Safdar,N.; John,G. T.; Pursell,K. J.; Munoz,P.; Patel,R.; Fortun,J.; Martin-Davila,P.; Philippe,B.; Philit,F.; Tabah,A.; Terzi,N.; Chatelet,V.; Kusne,S.; Clark,N.; Blumberg,E.; Julia,M. B.; Humar,A.; Houston,S.; Lass-Florl,C.; Johnson,L.; Dubberke,E. R.; Barron,M. A.; Lortholary,O.The Journal of infectious diseases 2009 ;200(6):1002-1011

Pulmonary zygomycosis in solid organ transplant recipients in the current eraSun,H. Y.; Aguado,J. M.; Bonatti,H.; Forrest,G.; Gupta,K. L.; Safdar,N.; John,G. T.; Pursell,K. J.; Munoz,P.; Patel,R.; Fortun,J.; Martin-Davila,P.; Philippe,B.; Philit,F.; Tabah,A.; Terzi,N.; Chatelet,V.; Kusne,S.; Clark,N.; Blumberg,E.; Julia,M. B.; Humar,A.; Houston,S.; Lass-Florl,C.; Johnson,L.; Dubberke,E. R.; Barron,M. A.; Lortholary,O.; Singh,N.; Zygomycosis Transplant Study GroupAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2009 ;9(9):2166-2171

Early intra-abdominal infections associated with orthotopic liver transplantationReid,G. E.; Grim,S. A.; Sankary,H.; Benedetti,E.; Oberholzer,J.; Clark,N. M.Transplantation 2009 ;87(11):1706-1711

Daptomycin for the treatment of vancomycin-resistant enterococcal infectionsGrim,S. A.; Hong,I.; Freeman,J.; Edwards,C.; Clark,N. M.The Journal of antimicrobial chemotherapy 2009 ;63(2):414-416

Nocardia in solid organ transplant recipients.Clark,N. M.; AST Infectious Diseases Community of,PracticeAmerican Journal of Transplantation 2009 ;9(Suppl 4):S70-7

The role of adjuvant agents in treating fungal diseasesGrim,ShelleeA; Clark,N. M.Current Fungal Infection Reports 2009 ;3(2):117-126

Safety of linezolid in patients with baseline thrombocytopeniaGrim,S. A.; Rene,L.; Gupta,S.; Clark,N. M.The Journal of antimicrobial chemotherapy 2008 ;62(4):850-851

Varicella-zoster virus and cerebral aneurysm: case report and review of the literatureBhayani,N.; Ranade,P.; Clark,N. M.; McGuinn,M.Clinical Infectious Diseases 2008 ;47(1):e1-3

Infectious complications associated with the use of rituximab for ABO-incompatible and positive cross-match renal transplant recipients.Grim,S. A.; Pham,T.; Thielke,J.; Sankary,H.; Oberholzer,J.; Benedetti,E.; Clark,N. M.Clinical transplantation 2007 ;21(5):628-632

Unusual presentation of cytomegalovirus enteritis after liver and kidney transplantation.Alhyraba,M.; Grim,S. A.; Benedetti,E.; Clark,N. M.Transplant Infectious Disease 2007 ;9(4):343-346

Rapid development of Acinetobacter baumannii resistance to tigecyclineReid,G. E.; Grim,S. A.; Aldeza,C. A.; Janda,W. M.; Clark,N. M.Pharmacotherapy 2007 ;27(8):1198-1201

Risk factors for wound healing complications in sirolimus-treated renal transplant recipients.Grim,S. A.; Slover,C. M.; Sankary,H.; Oberholzer,J.; Benedetti,E.; Clark,N. M.Transplantation proceedings 2006 ;38(10):3520-3523

Antimicrobial resistance among gram-positive organisms in the intensive care unitClark,N. M.; Hershberger,E.; Zervosc,M. J.; Lynch,J. P.,3rdCurrent Opinion in Critical care 2003 ;9(5):403-412

Antimicrobial resistance among gram-negative organisms in the intensive care unitClark,N. M.; Patterson,J.; Lynch,J. P.,3rdCurrent Opinion in Critical care 2003 ;9(5):413-423

Education
Medical School
  • University of Illinois College of Medicine
Residency
  • University of Michigan, Ann Arbor, Internal Medicine: General
Fellowship
  • University of Michigan, Ann Arbor, Infectious Diseases